A randomized, open-label, comparative evaluation of conversion from calcineurin inhibitor treatment to sirolimus treatment versus continued calcineurin inhibitor treatment in liver allograft recipients undergoing maintenance therapy
Phase of Trial: Phase III
Latest Information Update: 12 Jun 2013
At a glance
- Drugs Ciclosporin; Sirolimus; Tacrolimus
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Sponsors Pfizer
- 10 Jan 2012 Results published in the American Journal of Transplantation.
- 15 Sep 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 28 Nov 2005 New trial record.